首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
MONOSKI MIT EINER DOPPELBINDUNG.
摘要
申请公布号
DE3861229(D1)
申请公布日期
1991.01.17
申请号
DE19883861229
申请日期
1988.02.17
申请人
KAMMERER, MARTIN, DIPL.-ING. (FH), 7460 BALINGEN, DE
发明人
KAMMERER, MARTIN, DIPL.-ING. (FH), 7460 BALINGEN, DE
分类号
A63C5/03;(IPC1-7):A63C5/03
主分类号
A63C5/03
代理机构
代理人
主权项
地址
您可能感兴趣的专利
PROCESS FOR PRODUCING BEER STONE DISSOLVING AGENT AND BEER STONE DISSOLVING AGENT PRODUCED BY THE SAME
Support for an electrical contact arrangement
A multi-layer plastic film with the upper layer being yellow for use in agriculture
Cosmetic stick composition containing siloxane-based polyamides
Directional microphone with digital signal processing cancellation of side lobe signal
Peptide-containing alpha-ketoamide derivatives useful as cysteine and serine protease inhibitors
Method of using COX-2 inhibitors as anti-angiogenic agents
Pharmaceutical compositions of meloxicam with improved solubility and bioavailability
A system and method for creating, executing and maintaining cross-enterprise processes
Body weight support for skiers attached to skier's legs
Mammalian neuro-growth factor like protein
Nucleic acid encoding lipid transfer protein which exhibits SAR (systemic acquired resistance) by specific process
Tenderising treatment of meat by capacitor discharge between two electrodes via a liquid
Soluble gp80 and/or gp130 receptor sites sufficient to inhibit the binding of hIL6 to hepatocytes and other HBV-permissive cells
Peptide derivative compounds and their use in delivering biologically active agents across the blood-brain barrier
Ultra-high strength ausaged steels with excellent cryogenic temperature toughness and having a micro-laminate microstructure of austenite film layers and laths of martensite and bainite
Gaming table layout, and use of the table for playing high-low game
Levosimendan composition with alginic acid as a stability improving agent
Tablet container comprising a liquid component separated from a solid medicament
Use of a leptine sensitiser in combination with leptin to treat leptine resistance conditions (e.g. obesity)
